November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter…
LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing…
Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug discovery for priority viruses of pandemic and endemic…
Endura Mass the leading weight gain supplement brand from Cipla Health has partnered with Lucknow Super Giants the franchise team…
October 31, 2025 16:33 ET | Source: AMSC AYER, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AMSC® (NASDAQ: AMSC), a…
In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Alira Health today released its 2025 Global Drug Delivery System Trends Report,…
MIT's flagship conference returns November 4–6 to explore how to lead with confidence amid technological disruption. CAMBRIDGE, Mass., Oct. 22,…
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top…